Metoprolol Succinate Tablet, Extended Release
Product Images NDC 70518-4190

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Metoprolol Succinate (NDC 70518-4190). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Remedyrepack Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

Product Images & Figures Index

FDA Label Image

Remedy_label (Remedy Label)

Remedy_label (Remedy Label)
Metoprolol Succinate 100 mg extended-release oral tablets packaging label showing a quantity of 30 tablets. The label includes storage instructions, a barcode, a QR code, and repackager information for RemedyRepack Inc. The manufacturer is Oryza Pharmaceuticals Inc., Coral Springs, FL.*
FDA Label Image

Figure (Figure001)

Figure (Figure001)
A forest plot titled 'Results for Subgroups in MERIT-HE' showing relative risk and 95% confidence intervals across subgroups for Metoprolol Succinate Extended-Release Tablets versus placebo. The outcomes compared are Total Mortality, Total Mortality or All-Cause Hospitalization (Time to First Event), and Total Mortality or Hospitalization for Heart Failure (Time to First Event), with subgroups listed on the vertical axis and risk ratios on the horizontal axis.*
FDA Label Image

Structure (Structure001)

Structure (Structure001)
Chemical structure diagram of Metoprolol Succinate showing the molecular arrangement including aromatic ring, hydroxyl groups, and succinate component. The structure represents the extended-release form of Metoprolol Succinate.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.